M&A Deal Summary

Bio-Rad Acquires DiaMed

On October 2, 2007, Bio-Rad acquired life science company DiaMed

Acquisition Highlights
  • This is Bio-Rad’s 2nd transaction in the Life Science sector.
  • This is Bio-Rad’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2007-10-02
Target DiaMed
Sector Life Science
Buyer(s) Bio-Rad
Deal Type Add-on Acquisition

Target

DiaMed

Cressier, Switzerland
DiaMed GmbH, specializes in research and development, production and world wide services for laboratory diagnostic products.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bio-Rad

Hercules, California, United States

Category Company
Founded 1952
Sector Medical Products
Employees7,700
Revenue 2.6B USD (2024)
DESCRIPTION

Bio-Rad is a developer, manufacturer, and marketer of a broad range of medical tools and services to the life science research and clinical diagnostics markets. Bio-Rad was incorporated in 1952 and is based in Hercules, California.


DEAL STATS #
Overall 2 of 9
Sector: Life Science M&A 2 of 7
Type: Add-on Acquisition M&A Deals 2 of 7
Country: Switzerland M&A 1 of 1
Year: 2007 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-08-18 MJ Research

Waltham, Massachusetts, United States

MJ Research, Inc. is a biotechnology company specializing in premium instruments and consumables used in modern biological research. MJ Research pioneered the use of Peltier-effect technology and has introduced a number of other innovations in the thermal-cycling field.

Buy $47M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-05 QuantaLife

Pleasanton, California, United States

QuantaLife, Inc. is a life science company that manufactures and markets products based on their proprietary nucleic acid testing method.

Buy $162M